A study to evaluate whether macitentan is an effective and safe treatment for patients with heart failure with preserved ejection fraction and pulmonary vascular disease (SERENADE). Abstract. Presented at HFA Heart Failure; Madrid - Shah, SJ; Bonderman, D; Borlaug, BA (2022)
et al.